BroadOak Capital Partners, with headquarters in Washington, DC, and San Francisco, is a life-sciences focused boutique financial institution that provides direct investment and investment banking services to companies in research tools and consumables, diagnostics, biopharma services, and adjacent markets. BroadOak has led or participated in investments in more than fifty companies across multiple funds and investment vehicles.
Location: United States, California, Brisbane
Employees: 11-50
Founded date: 2006
Portfolio 65
| Date | Name | Website | Total Raised | Location |
| 18.07.2024 | Hudson Rob... | hudsonrobotics.com | - | United Sta... |
| 27.04.2024 | CS Genetic... | csgenetics.com | - | United Kin... |
| 27.04.2024 | Fluidic An... | fluidic.com | $31M | United Kin... |
| 14.03.2024 | RoosterBio... | roosterbio.com | $36.75M | United Sta... |
| 26.10.2023 | PAK BioSol... | pakbiosolutions.com | - | United Sta... |
| 26.10.2023 | Pluristyx,... | pluristyx.com | - | United Sta... |
| 04.08.2023 | Nanocellec... | nanocellect.com | $46.8M | United Sta... |
| 23.04.2023 | Indee Labs | indeelabs.com | $5.9M | Australia,... |
| 30.01.2023 | PubGrade | pubgrade.com | - | Germany, N... |
| 21.01.2023 | CDI Labora... | cdi.bio | - | United Sta... |
Show more
Persons 5
| Date | First Name | Last Name | Title | Location | |||
| - | Daniel | Friedman | Principal | linkedin.c... | - | d*******n@... | - |
| - | Aaron | Goldman | Operating ... | linkedin.c... | - | a******n@x... | - |
| - | Austin | Duke | Managing D... | linkedin.c... | - | a***e@broa... | - |
| - | Max | Weis | Associate | linkedin.c... | - | m***s@broa... | - |
| - | Bill | Snider | Partner | linkedin.c... | - | b*****r@br... | - |
News 23
| Date | Title | Description |
| 23.01.2024 | ZoBio Sells to Oncodesign Services | BroadOak Capital Partners advised ZoBio on the sale of the company to Oncodesign Services. ZoBio is a leading provider of biophysics-based small molecule drug discovery services.. The full press release is below. Dijon, France & Leiden,... |
| 21.12.2023 | Pluristyx Closes Major Fundraising Round | BroadOak Capital Partners led Pluristyx’s latest fundraising round, which featured participation from existing investors and key opinion leaders in the life sciences sector. |
| 11.07.2023 | celares GmbH Sells to Biosynth | BroadOak Capital Partners advised Biosynth on the acquisition of celares GmbH. Celares provides customized bioconjugation solutions for Pharma and IVD industries. |
| 29.06.2023 | Genomenon Acquires Boston Genetics | Genomenon, a BroadOak portfolio company and a leader in genomic intelligence, acquired Boston Genetics, a genomics interpretation and curation company. |
| 12.04.2023 | Indee Labs Investment from BroadOak BioTools Venture Fund | BroadOak Capital Partners invested in Indee Labs out of its BioTools Venture Fund to support the development of Hydropore, which enables modified immune cell research and development with improved yield and function using a simple workflow,... |
| 09.01.2023 | BroadOak Invests in CDI Laboratories | BroadOak invested in CDI Labs, a provider of serological biomarker discovery services and monoclonal antibody manufacturing and validation services, to expand and scale antibody biomarker discovery platforms. |
| 09.01.2023 | Sanguine Biosciences Partners with BroadOak | Sanguine is a leader in custom specimen procurement used by biopharmaceutical companies to accelerate precision medicine and cell & gene therapy R&D. Our investment will help Sanguine expand laboratory operations, leukapheresis offe... |
| 09.01.2023 | PBS Biotech Raises $22M | BroadOak portfolio company PBS Biotech, an innovative manufacturer of single-use bioreactors, has completed a $22 million financing that will be used to improve the company’s products portfolio, expand its process development services capab... |
| 14.12.2022 | FujiFilm Invests in PhenoVista Biosciences | BroadOak portfolio company PhenoVista Biosciences, a leading provider of both custom and off-the-shelf imaging-based assay services, received an investment from Fujifilm’s Life Sciences Corporate Venture Capital Fund to accelerate developme... |
| 22.11.2022 | BioCare Medical Acquires Empire Genomics | BioCare Medical, a leading provider of innovative, automated immunohistochemistry (IHC) and FISH (Fluorescent in situ hybridization) instrumentation and reagents, acquired BroadOak portfolio company Empire Genomics, a market leader in molec... |
Show more
Mentions in press and media 5
| Date | Title | Description |
| 22.06.2022 | Kemp Proteins Secures $5M Growth Financing from BroadOak Capital Partners | "Broadoak’s growth investment will enable us to acquire several S.I.P. fermenters, digitized controllers with off-site monitoring capabilities and additional lab space." - Michael Keefe, CEO Kemp Proteins FREDERICK, Md. (PRWEB) Ju... |
| 03.11.2021 | Interpace Biosciences Announces New $8 Million Term Loan with BroadOak Capital Partners and Repayment of Private Equity Loans - Form 8-K | Interpace Biosciences Announces New $8 Million Term Loan with BroadOak Capital Partners and Repayment of Private Equity Loans PARSIPPANY, NJ, November 2, 2021 (GLOBE NEWSWIRE) - Interpace Biosciences, Inc. ("Interpace" or the &quo... |
| 02.11.2021 | Interpace Biosciences Announces New $8 Million Term Loan with BroadOak Capital Partners and Repayment of Private Equity Loans | PARSIPPANY, NJ, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced that it, along with its subsidiaries, has entered into a new $8 million term loan with BroadOak Fund ... |
| 02.11.2021 | Interpace Biosciences Announces New $8 Million Term Loan with BroadOak Capital Partners and Repayment of Private Equity Loans | PARSIPPANY, NJ, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced that it, along with its subsidiaries, has entered into a new $8 million term loan with BroadOak Fund ... |
| 22.05.2016 | Molecular Diagnostics Company Empire Genomics Raised $1.75M in Funding | Empire Genomics, a Buffalo, NY-based molecular diagnostics company, raised $1.75m financing round. The round was led by existing investor BroadOak Capital Partners with participation from Rand Capital Corporation (NASDAQ: RAND). The company... |